{"id":"https://openalex.org/W2102449174","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1441","title":"Therapeutic Nanoparticles for Drug Delivery in Cancer","display_name":"Therapeutic Nanoparticles for Drug Delivery in Cancer","alternate_titles":[],"publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W2102449174","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1441","mag":"2102449174","pmid":"https://pubmed.ncbi.nlm.nih.gov/18316549"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-07-1441","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1441","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-1441","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2102449174"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052028612","display_name":"Kwangjae Cho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kwangjae Cho","raw_affiliation_strings":["1Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine and","Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine and","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]},{"raw_affiliation_string":"Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100407859","display_name":"Xu Wang","orcid":"https://orcid.org/0000-0002-2619-9463","observed_orcids":["https://orcid.org/0000-0002-2619-9463","https://orcid.org/0009-0005-7275-0817"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xu Wang","raw_affiliation_strings":["1Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine and","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022867429","display_name":"Shuming Nie","orcid":"https://orcid.org/0000-0002-7328-1144","observed_orcids":["https://orcid.org/0000-0002-7328-1144"]},"institutions":[{"id":"https://openalex.org/I130701444","display_name":"Georgia Institute of Technology","ror":"https://ror.org/01zkghx44","country_code":"US","type":"education","lineage":["https://openalex.org/I130701444"]},{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shuming Nie","raw_affiliation_strings":["2Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, Georgia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, Georgia","institution_ids":["https://openalex.org/I130701444","https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Zhuo (Georgia) Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zhuo (Georgia) Chen","raw_affiliation_strings":["1Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine and","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107600360","display_name":"Dong Moon Shin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dong M. Shin","raw_affiliation_strings":["1Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine and","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4793,"has_fulltext":false,"cited_by_count":3341,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97536946,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"14","issue":"5","first_page":"1310","last_page":"1316"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-nanotherapeutics","display_name":"cancer nanotherapeutics","score":0.906000018119812},{"id":"https://openalex.org/keywords/nanoparticles","display_name":"nanoparticles","score":0.5600000023841858},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.7979999780654907},{"id":"https://openalex.org/keywords/enhanced-permeability-and-retention-effect","display_name":"enhanced permeability and retention effect","score":0.8299999833106995},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8320000171661377},{"id":"https://openalex.org/keywords/active-targeting","display_name":"active targeting","score":0.8029999732971191},{"id":"https://openalex.org/keywords/passive-targeting","display_name":"passive targeting","score":0.6890000104904175},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.703000009059906},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.968999981880188},{"id":"https://openalex.org/keywords/multifunctional-nanoparticles","display_name":"multifunctional nanoparticles","score":0.8029999732971191},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.7579203844070435},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.6067934036254883},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.568343997001648},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5391381978988647},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5020716190338135},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4897480010986328},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.48404616117477417},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4785519242286682},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.4395481050014496},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40873947739601135},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3874560594558716},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3508002758026123},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.28956884145736694},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.18912559747695923},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.18836072087287903},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12859642505645752},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09626901149749756},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0660291314125061},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D050997","descriptor_name":"Nanomedicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-07-1441","doi":"https://doi.org/10.1158/1078-0432.ccr-07-1441","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-1441","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:18316549","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18316549","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.423.6874","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.423.6874","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.virlab.virginia.edu/Nanoscience_class/lecture_notes/Lecture_14_Materials/Nano Medicine/Therapeutic Nanoparticles for Drug Delivery in Cancer - Cho Wang Nie Zhuo Chen Shin.pdf .pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3679846269","display_name":"Nanotechnology Linking Biomarkers with Cancer Behavior","funder_award_id":"R01CA108468","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7643087248","display_name":"Emory-GA Tech Nanotechnology Center for Personalized an*","funder_award_id":"U54CA119338","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7933644463","display_name":"SPORE in Head and Neck Cancer","funder_award_id":"P50CA128613","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W1514533803","https://openalex.org/W1573363574","https://openalex.org/W1832002274","https://openalex.org/W1964868194","https://openalex.org/W1965918908","https://openalex.org/W1978183755","https://openalex.org/W1982267003","https://openalex.org/W1984447304","https://openalex.org/W1986269836","https://openalex.org/W1992885568","https://openalex.org/W1993895985","https://openalex.org/W1997772128","https://openalex.org/W2002975193","https://openalex.org/W2005196200","https://openalex.org/W2006434892","https://openalex.org/W2006682004","https://openalex.org/W2023268526","https://openalex.org/W2030855909","https://openalex.org/W2033852473","https://openalex.org/W2037048276","https://openalex.org/W2041759339","https://openalex.org/W2046528901","https://openalex.org/W2046851174","https://openalex.org/W2048018575","https://openalex.org/W2052987601","https://openalex.org/W2056940735","https://openalex.org/W2064255874","https://openalex.org/W2071385362","https://openalex.org/W2072339916","https://openalex.org/W2073055302","https://openalex.org/W2074772243","https://openalex.org/W2077329950","https://openalex.org/W2078775260","https://openalex.org/W2080879368","https://openalex.org/W2085733813","https://openalex.org/W2088206323","https://openalex.org/W2091108794","https://openalex.org/W2097535374","https://openalex.org/W2099616702","https://openalex.org/W2100225360","https://openalex.org/W2103665144","https://openalex.org/W2110106434","https://openalex.org/W2110688302","https://openalex.org/W2118844383","https://openalex.org/W2121429936","https://openalex.org/W2123494134","https://openalex.org/W2125708747","https://openalex.org/W2126947618","https://openalex.org/W2130648029","https://openalex.org/W2133591717","https://openalex.org/W2136797728","https://openalex.org/W2138816938","https://openalex.org/W2141395077","https://openalex.org/W2151091220","https://openalex.org/W2152920690","https://openalex.org/W2153017356","https://openalex.org/W2163294691","https://openalex.org/W2164380696","https://openalex.org/W2170083676","https://openalex.org/W2170952917","https://openalex.org/W2171792381","https://openalex.org/W2315117765","https://openalex.org/W2902693141","https://openalex.org/W4297604829"],"related_works":["https://openalex.org/W2884606057","https://openalex.org/W2887301811","https://openalex.org/W4224436805","https://openalex.org/W2745610816","https://openalex.org/W2134726513","https://openalex.org/W2149247492","https://openalex.org/W2232386288","https://openalex.org/W4405948369","https://openalex.org/W2080376735"],"abstract_inverted_index":{"Cancer":[0],"nanotherapeutics":[1],"are":[2,6,61,178,184],"rapidly":[3],"progressing":[4],"and":[5,22,31,49,86,89,131,175,183,196],"being":[7,154,180],"implemented":[8],"to":[9,52,64,70,95,149],"solve":[10],"several":[11],"limitations":[12],"of":[13,25,39,79,115,127,159,163,172,192],"conventional":[14,132],"drug":[15],"delivery":[16],"systems":[17],"such":[18,81],"as":[19,82,188],"nonspecific":[20],"biodistribution":[21,38],"targeting,":[23],"lack":[24],"water":[26],"solubility,":[27],"poor":[28],"oral":[29],"bioavailability,":[30],"low":[32],"therapeutic":[33,117],"indices.":[34],"To":[35],"improve":[36],"the":[37,58,76,90,113,125,147,160,168,186,189],"cancer":[40,71,198],"drugs,":[41],"nanoparticles":[42,177],"have":[43,146],"been":[44],"designed":[45],"for":[46],"optimal":[47],"size":[48],"surface":[50],"characteristics":[51],"increase":[53],"their":[54,66,83],"circulation":[55],"time":[56],"in":[57,151,167],"bloodstream.":[59],"They":[60],"also":[62,136],"able":[63],"carry":[65],"loaded":[67],"active":[68,100],"drugs":[69],"cells":[72,152],"by":[73,156],"selectively":[74],"using":[75,103,143],"unique":[77],"pathophysiology":[78],"tumors,":[80],"enhanced":[84],"permeability":[85],"retention":[87],"effect":[88],"tumor":[91,110],"microenvironment.":[92],"In":[93],"addition":[94],"this":[96],"passive":[97],"targeting":[98,101],"mechanism,":[99],"strategies":[102],"ligands":[104],"or":[105,139],"antibodies":[106],"directed":[107],"against":[108],"selected":[109],"targets":[111],"amplify":[112],"specificity":[114],"these":[116],"nanoparticles.":[118,144],"Drug":[119],"resistance,":[120,165],"another":[121],"obstacle":[122],"that":[123],"impedes":[124],"efficacy":[126],"both":[128],"molecularly":[129],"targeted":[130],"chemotherapeutic":[133],"agents,":[134],"might":[135],"be":[137],"overcome,":[138],"at":[140],"least":[141],"reduced,":[142],"Nanoparticles":[145],"ability":[148],"accumulate":[150],"without":[153],"recognized":[155],"P-glycoprotein,":[157],"one":[158],"main":[161],"mediators":[162],"multidrug":[164],"resulting":[166],"increased":[169],"intracellular":[170],"concentration":[171],"drugs.":[173],"Multifunctional":[174],"multiplex":[176],"now":[179],"actively":[181],"investigated":[182],"on":[185],"horizon":[187],"next":[190],"generation":[191],"nanoparticles,":[193],"facilitating":[194],"personalized":[195],"tailored":[197],"treatment.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2102449174","counts_by_year":[{"year":2026,"cited_by_count":64},{"year":2025,"cited_by_count":111},{"year":2024,"cited_by_count":143},{"year":2023,"cited_by_count":150},{"year":2022,"cited_by_count":172},{"year":2021,"cited_by_count":197},{"year":2020,"cited_by_count":233},{"year":2019,"cited_by_count":257},{"year":2018,"cited_by_count":253},{"year":2017,"cited_by_count":266},{"year":2016,"cited_by_count":299},{"year":2015,"cited_by_count":251},{"year":2014,"cited_by_count":235},{"year":2013,"cited_by_count":212},{"year":2012,"cited_by_count":191}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
